findmyKOL
Clinical trialNCT01121120TerminatedPhase 2Interventional

Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients

SponsorTarix PharmaceuticalsEnrollment75Hodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Hospital

    Duarte, California, United States

  • Emory University

    Atlanta, Georgia, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • Iu Simon Cancer Center

    Indianapolis, Indiana, United States

  • Washington University

    St Louis, Missouri, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Stony Brook

    Long Island City, New York, United States

  • Montefiori Medical Center

    The Bronx, New York, United States

  • Huntsman Cancer Institute

    Salt Lake City, Utah, United States

  • University of Virginia Health System

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2010
Primary completion
31 Dec 2020
Completion
31 Dec 2020
Last update posted
8 Dec 2020
Registered enrollment
75
Registry id
NCT01121120

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.